Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

AKLI | Akili Inc

Healthcare | Health Information Services | USA | NASD

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	49.48%	Shs Outstand	-	Perf Week	-15.29%
Market Cap	43.70M	Forward P/E	-	EPS next Y	-0.68	Insider Trans	-0.02%	Shs Float	39.50M	Perf Month	-40.92%
Income	-8.34M	PEG	-	EPS next Q	-0.22	Inst Own	38.50%	Short Float / Ratio	0.30% / 2.63	Perf Quarter	-51.38%
Sales	0.00M	P/S	-	EPS this Y	68.58%	Inst Trans	20.01%	Short Interest	0.12M	Perf Half Y	-64.61%
Book/sh	1.06	P/B	0.53	EPS next Y	16.80%	ROA	-6.63%	Target Price	4.00	Perf Year	-79.74%
Cash/sh	1.36	P/C	0.41	EPS next 5Y	-	ROE	-7.08%	52W Range	0.53 - 2.76	Perf YTD	-50.08%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-9.06%	52W High	-79.74%	Beta	1.39
Dividend %	-	Quick Ratio	8.27	Sales past 5Y	-	Gross Margin	-	52W Low	6.45%	ATR	0.10
Employees	-	Current Ratio	8.27	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	26.36	Volatility	17.79% 13.45%
Optionable	Yes	Debt/Eq	0.21	EPS Q/Q	-121.00%	Profit Margin	-	Rel Volume	0.99	Prev Close	0.55
Shortable	Yes	LT Debt/Eq	0.11	Earnings	Aug 10 AMC	Payout	-	Avg Volume	45.64K	Price	0.56
Recom	1.50	SMA20	-36.05%	SMA50	-44.50%	SMA200	-56.92%	Volume	17,571	Change	1.67%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-18-22	Initiated	BofA Securities	Neutral	$2
Oct-25-22	Initiated	Credit Suisse	Outperform	$5
Sep-06-22	Initiated	Cowen	Outperform

Sep-21-23 08:00AM	Akili Releases EndeavorOTC on Android Devices, Expanding Treatment Access for Millions of Adults with ADHD (Business Wire) -16.06%
Sep-15-23 03:03AM	Insider Sell: CEO Martucci Walter Edward II Sells 2,353 Shares of Akili Inc (GuruFocus.com) -28.66%
Sep-13-23 01:16PM	Digital health startup Akili cuts staff by 40%, abandons prescription model (American City Business Journals)
08:00AM	Akili Announces Business Transformation, Focusing on Non-prescription Model (Business Wire)
Aug-14-23 09:26AM	Akili, Inc. (NASDAQ:AKLI) Q2 2023 Earnings Call Transcript (Insider Monkey)
06:43AM	Loading…
Aug-11-23 06:43AM	Q2 2023 Akili Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-10-23 04:01PM	Akili Reports Second Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Jul-10-23 07:00AM	Akili to Host Second Quarter Financial Results Conference Call and Webcast on Thursday, August 10 at 4:30 p.m. ET (Business Wire)
Jun-08-23 01:20PM	EndeavorOTC Elevates ADHD Treatment: Unprecedented Mobile Game Therapy for Adults (Benzinga)
Jun-07-23 07:00AM	Akili Releases EndeavorOTCTM Video Game Treatment to Improve Attention in Adults with ADHD (Business Wire)
May-31-23 07:00AM	Akili to Present Clinical Data from Pivotal Trial of Video Game Treatment in Adolescents with ADHD at 2023 ASCP Annual Meeting and Elevate Psych Congress (Business Wire)
May-12-23 11:12AM	Q1 2023 Akili Inc Earnings Call (Thomson Reuters StreetEvents) +11.90%
May-11-23 04:01PM	Akili Reports First Quarter 2023 Financial Results and Provides Business Update (Business Wire)
May-04-23 02:00AM	PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akilis EndeavorRx® Video Game-Based Therapeutic (Business Wire) -6.88%
May-03-23 04:56PM	Game-Changing ADHD Treatment: Akili's EndeavorRx Shows Significant Improvement in Adult Attention Functioning (Benzinga) +46.79%
07:00AM	Loading…
07:00AM	Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akilis EndeavorRx® Video Game-Based Therapeutic (Business Wire)
Apr-13-23 08:00AM	Akili to Host First Quarter Financial Results Conference Call and Webcast on Thursday, May 11 at 4:30 p.m. ET (Business Wire)
Mar-13-23 11:51AM	Akili, Inc. (NASDAQ:AKLI) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.97%
Mar-08-23 08:32AM	Q4 2022 Akili Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-07-23 04:01PM	Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire) -5.38%
Feb-08-23 11:37AM	Akili, Inc.'s (NASDAQ:AKLI) market cap up US$26m last week, benefiting both individual investors who own 26% as well as insiders (Simply Wall St.) +14.74%
Feb-06-23 07:00AM	Akili to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, March 7 at 4:30 p.m. ET (Business Wire)
Feb-02-23 07:00AM	Akili to Participate in the Cowen 43rd Annual Health Care Conference (Business Wire)
Jan-06-23 10:43AM	Akili to Champion Digital Therapeutics in Conjunction with J.P. Morgan Healthcare Conference (Business Wire) -14.07%
Jan-05-23 07:00AM	Pivotal Trial of EndeavorRx in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes (Business Wire) +25.00%
Dec-29-22 02:44PM	Morgan Stanley Initiates Coverage On This Digital Therapeutics Stock With Attractive View (Benzinga) +5.97%
Dec-27-22 11:05AM	Chamath Palihapitiya Stocks: 10 Stocks Picked in the Last 10 Years (Insider Monkey) -13.79%
Dec-01-22 07:00AM	Akili Announces ADHD Expert Dr. Scott Kollins to Join as Chief Medical Officer (Business Wire) +10.96%
Nov-19-22 07:52AM	Akili Third Quarter 2022 Earnings: EPS: US$1.38 (vs US$16.67 loss in 3Q 2021) (Simply Wall St.)
Nov-10-22 04:01PM	Akili Reports Third Quarter 2022 Financial Results and Company Update (Business Wire)
11:53AM	Loading…
Nov-01-22 11:53AM	Down More Than 50%: These 3 Strong Buy Stocks Are Too Cheap to Ignore (TipRanks) +5.45%
Oct-27-22 07:00AM	Financial Industry Veteran Mary Hentges Joins Akilis Board of Directors (Business Wire) -5.29%
Oct-19-22 07:00AM	Akili to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 10 at 4:30 p.m. ET (Business Wire)
Sep-21-22 07:00AM	Akili Launches EndeavorRx® Expedition - A Direct-to-Patient Product Registry (Business Wire) -9.84%
Sep-19-22 07:00AM	Akili to Participate in LifeSci Partners HealthTech Symposium (Business Wire) -14.03%
Aug-22-22 04:08PM	Akili 'took the last decade to clinically validate' its video game treatment for ADHD: CEO (Yahoo Finance Video) -49.18%

Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its leveraging technologies designed to directly target the brain establishes a new category of medicine that is validated through clinical trials like a drug or medical device, but experienced like entertainment. The company is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Martucci Walter Edward II	Chief Executive Officer	Sep 11	Sale	1.05	2,353	2,471	3,150,180	Sep 14 08:30 AM
Franklin Matthew	President & COO	Sep 11	Sale	1.05	1,728	1,814	753,898	Sep 14 08:29 AM
Studer Jacqueline	Chief Legal Officer	Sep 11	Sale	1.05	1,130	1,186	348,292	Sep 14 08:31 AM
Shanbhag Santosh	Chief Financial Officer	Sep 11	Sale	1.05	830	872	323,636	Sep 14 08:28 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AKLI | Akili Inc

Upgrade your FINVIZ experience